Alkermes
tumor targeted split fusion protein program principal scientist research oncology | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
100 of 144
Related slides by other companies
Mink Therapeutics
IPO
October 2021
agent clinical programs in oncology and immune mediated diseases | Mink Therapeutics
Fusion Pharmaceuticals
IPO
June 2020
chief scientific james chief medical officer officer fusion lead program targeted alpha therapeutic | Fusion Pharmaceuticals
Fusion Pharmaceuticals
Investor Presentation
August 2023
programs fusion growing and diverse portfolio | Fusion Pharmaceuticals
Fusion Pharmaceuticals
Investor Presentation
November 2023
programs fusion growing and diverse portfolio | Fusion Pharmaceuticals
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io